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INTRODUCTION 
 
  
Hearing screening at birth has been omitted by most of the centers in 
India at the moment. The incidence of congenital hearing loss in the 
newborn population is  greater than the combined incidence of all the 
metabolic conditions that we  currently screen for with blood tests.26 
Significant hearing loss is one of the most  major abnormalities present at 
birth About one in every thousand children is born profoundly deaf,four 
times as many are born with moderate or severe bilateral hearing loss.18 
Infants in Neonatal intensive care units are 10 – 20 times more  likely to 
have significant hearing loss than healthy population. 
 In 1993 a consensus statement from the National Institute of Health 
(NIH)  recommended universal newborn hearing screening by the age of 3 
months and also stated that otoacoustic emission might be the technology 
used for screening27.  
These recommendations were based on the following: (1) the 
incidence of hearing loss is 1 to 6 per 1000; (2) only one half of the infants 
with hearing loss are discovered with high-risk screening; (3) the current 
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average age at diagnosis of hearing loss is 2.5 years; and (4) early 
identification and treatment by the age of 6 months will improve outcomes.8  
As the first year of life is substantially critical in the development of 
brain, absence of auditory experience during this period significantly retards 
the child’s overall development. Thus  there is a need for early identification 
of hearing loss through Newborn Hearing Screening Programmes which is 
already existing in developed countries.10 
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REVIEW OF LITERATURE 
EPIDEMIOLOGY 
According to the current estimates permanent hearing loss of greater 
than 25  decibel hearing level in poorer ear is present in atleast 4(1.1 to 6)   
per 1000.16 As many as half of these infants have no risk factors for hearing 
loss; thus hearing loss may not be suspected until the child misses language  
milestones. The prevalence of hearing loss in high risk infants is estimated to 
be between 2.5 and 10%.20,23. Newborn hearing program aims to detect  
hearing impairment including unilateral or bilateral sensory or  conductive 
hearing loss averaging 30 – 40 decibel or more in frequency region 500 
through 4000 HZ. Hearing impairment in this range will have most impact 
on speech acquisition27. 
In India, incidence of hearing impairment in neonates ( at risk and not 
at risk) ranges from 6 – 60 per 1000 neonates with an average of 4 per 1000 
neonates.4 Another survey in India has shown  4 out of every 1000 infants 
born were found to have severe hearing loss.21 
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NEED FOR HEARING ASSESSMENT IN NEWBORN 
The first three years of life are most important for language and 
speech development. Consequently, for many infants and young children 
with unidentified hearing impairment much of the crucial period for 
language and speech development may be  lost. Moderate to profound 
hearing loss in early infancy has been shown to be associated with impaired 
language development, as auditory stimuli during this period are critical to 
development of speech and language skills27.  
This in turn leads to lower reading abilities, poor academic 
achievement and fewer  career opportunities (Task Force on newborn and 
infant hearing). 
 The personal and social impacts of hearing loss are enormous. People 
with hearing impairment "often have less desirable jobs  and incomes than 
people without hearing impairment." Lifetime costs of each case of 
congenital deafness have been estimated at over $1 million, and "programs 
and services for the communicatively handicapped are estimated to cost 
$23.4 billion per year in the United States." Costs of lost earnings to people 
resulting from the disability caused by hearing loss was estimated to be over 
$1.25 billion annually in 1990. Other burdens arise because of "emotional 
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stress, breakdowns in family communication, and isolation of hearing 
impaired persons from peers and educational systems." 
A child’s hearing impairment should therefore be identified as early in 
life as possible so that he or she can receive timely and appropriate 
intervention. The interventions will then take full advantage of the plasticity 
of child’s developing nervous system optimizing his or her social, 
emotional, psychological and academic development.11,22,25 
In 1993,the NIH recommended that all children should be screened 
for hearing loss by 3 months. In 1994,Joint committee on infant 
hearing(JCIH)  endorsed this recommendation and suggested that screening 
should take place before a newborn was discharged from the hospital where 
they were born to ensure most of the children could be screened. 
Universal newborn screening for hearing loss began in January 1, 
2003. The goals are detection of hearing loss before 3 months of age , and 
the initiation of appropriate intervention no later than 6 months of age. 
American Academy of Paediatrics(AAP) and Joint Committee on Infant 
Hearing(JCIH) also recommend the same. The Early Hearing Detection and 
Intervention (EHDI) Program of the Center for Disease Control and 
Prevention(CDC) also recommends the “1-3-6 plan,”  ie all infants to be 
screened by age 1 month, all children who do not pass the screening to 
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receive diagnostic audiological testing by age 3 months, and all children 
with confirmed hearing loss to be enrolled in an appropriate intervention  
program by the age of 6 months.25 
Prior to universal newborn hearing screening implementation,average 
age of identification of hearing loss was 20.2 months.Two years after 
universal newborn  hearing screening implementation,average age of 
diagnosis has greatly improved to 3.8 months of age.17,22 
DEVELOPMENT OF EAR3 
 AURICLE – About the 6th week of embryonic life, a series of 6 
tubercles appear around the first branchial cleft.They coalesce to form the 
auricle. Tragus develops from the tubercle of first arch while rest of pinna 
develops from the remaining five tubercles of the second arch. 
 EXTERNAL AUDITORY MEATUS – It develops from the first 
branchial cleft.By 16th week of embryonic life, cells proliferate from the 
bottom of ectodermal cleft and form a meatal plug. Recanalisation of this 
plug forms the epithelial lining of the bony meatus. 
TYMPANIC MEMBRANE – It develops from all the 3 germinal 
layers.  
Outer epithelial layer is formed by the ectoderm, inner mucosal layer 
by the endoderm and the middle fibrous layer by the mesoderm. 
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MIDDLE EAR CLEFT – The Eustachian tube, tympanic cavity, 
attic, antrum and mastoid air cells develop from the first and second 
pharyngeal pouches.Malleus and Incus are derived from mesoderm of the 
first arch while the Stapes from the second arch. 
INNER EAR –Ectoderm in the region of hind brain thickens to form 
an auditory placode which is invaginated to form the auditory vesicle or 
otocyst.This differentiates into the endolymphatic duct and sac; the 
utricle,semicircular ducts; and saccule and the cochlea 
 
TABLE – 1 
TIMING OF DEVELOPMENT OF EAR IN THE WEEK OF 
GESTATION 
 
Development Pinna Meatus 
Middle 
Ear 
Vestibular 
Labyrinth 
Cochlea 
BEGINS 6th 8th 3rd 3rd 3rd 
COMPLETES 20th 28th 30th 20th 20th 
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ANATOMY  OF EAR 
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MECHANISM OF HEARING 
 A sound signal  in the environment is collected by the pinna, passes  
through the external  auditory canal and strikes the tympanic membrane. 
 
      Vibrations of the tympanic membrane are transmitted to the stapes 
footplate through a chain of ossicles coupled to the tympanic membrane. 
 
           Movements of the stapes footplate cause pressure changes in the 
labyrinthine fluids which move the basilar membrane.This stimulates the 
hair cells of organ of corti.It is the hair cells which convert mechanical 
energy into electrical impulse 
                           
            Hair cells are innervated by dendrites of bipolar cells of spiral 
ganglion.Axons of these bipolar cells form the cochlear division of 8th 
cranial nerve which enters the brain at ponto medullary junction. 
    
 On entering the brainstem,fibres bifurcate.The upper division ends in  
DORSAL COCHLEAR NUCLEUS (DCN) BILATERALLY.The lower  
division ends in VENTRAL COCHLEAR NUCLEUS(VCN). 
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 II order neurons from DCN ascend in LATERAL LEMNISCUS 
while II order neurons from VCN relay in SUPERIOR OLIVARY 
NUCLEUS. From the superior olivary nucleus, III order neurons ascend in 
the lateral lemniscus  
 
 Lateral lemniscal fibres terminate in INFERIOR COLLICULUS.  
Intercollicular commissural fibers  transmit impulses between the colliculi. 
 
From the inferior colliculus,impulses are projected into 
IPSILATERAL MEDIAL GENICULATE BODY 
 
 From the medial geniculate body,impulses are projected to AREA 41 
or HESCHL”S GYRUS(Superior Temporal Gyrus) known as Primary 
Auditory Cortex.Some impulses are also projected to AREA 42, the 
Auditory Association Area. 
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AUDITORY PATHWAY 
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HEARING LOSS2 
 Hearing loss falls into four major categories : 
• Sensory neural  loss is the result of abnormal development or 
damage to the Cochlear hair cells or auditory nerve. 
• Conductive loss is the result of interference in the transmission of 
sound from the external auditory canal to the inner ear.The most 
common cause for conductive hearing loss is fluid in the middle ear or 
middle ear effusion. Less common are anatomic causes such as 
microtia, canal stenosis,or stapes fixation that often occur in infants 
with craniofacial malformation.  
• Auditory dyssynchrony or auditory neuropathy – Here the cochlea 
receives sounds normally ; however the transfer of signal from the 
cochlea to the auditory nerve is abnormal.The etiology of this 
condition is not understood ; however,babies who have severe 
hyperbilirubinemia,prematurity,hypoxia and immune disorders are at 
increased risk. 
• Central hearing loss – In this type of hearing loss there is an intact 
auditory canal and inner ear and normal neurosensory pathways but 
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abnormal auditory processing at higher levels of the central nervous 
system. 
HEARING  LOSS  -  CAUSES 
The causes fall into three basic categories. 
• Genetically inherited hearing loss accounts for approximately 50% of 
all cases. 70 % are autosomal recessive,15% autosomal dominant and 
15% with other types of transmission.The most common genetic cause 
of hearing loss is a mutation in the connexin 26 gene,located on 
chromosome 13q11-12.Deletion of mitochondrial gene 
12SrRNA,A1555G  is associated with a predisposition for hearing 
loss after exposure to aminoglycoside antibiotics. The majority of 
these are non-syndromic. The other cases are syndromic. In this type 
there are other clinical manifestations along with the hearing loss. 
Usher syndrome is an example of a syndrome that includes hearing 
loss. 
• In approximately 25% of childhood hearing loss,a nongenetic cause is 
identified. Hearing loss is thought to be secondary to injury to the 
developing auditory system in the intrapartum or perinatal period.The 
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injury may be due to infection, hypoxia, ischaemia, metabolic disease, 
ototoxic medication or hyperbilirubinemia. Congenital 
Cytomegalovirus infection is the most common cause of 
nonhereditary sensoryneural hearing loss.Approximately 1% of all 
infants are born with CMV infection.Of these 10% have clinical signs 
of infection at birth(small for gestational age, hepatosplenomegaly, 
jaundice, thrombocytopenia, neutropenia, intracranial calcification, 
skin rash) and 50 -60%  of these infants develop hearing loss.Hearing 
loss also develops in 10 – 15% of those who are asymptomatic at 
birth. Sensoryneural deafness is the single most common finding 
among infants with Congenital Rubella Syndrome(when maternal 
infection occurs before 11 weeks of gestation). 
• In the remaining 25% there is no identifiable cause. 
TABLE-2 
SEVERITY OF HEARING LOSS 
 
MILD 
 
15 -30 dB HEARING LOSS 
 
MODERATE 
 
30 -50 dB HEARING LOSS 
 
SEVERE 
 
50 -70 dB HEARING LOSS 
 
PROFOUND 
 
    70+ dB HEARING LOSS 
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SCREENING METHODS 
Previously, the standard hearing test was behavioral assessment 
(Murphy’s Sound localization method).Under this technique, the infant 
would be subjected to a sound while observer watches a reaction from the 
baby in response to it (i.e., testing an infant's "startle response"). The method 
is often limited by the observer's ability to subjectively assess the infant's 
reaction to the sound at the time of the test.  
Over the last two decades, more sophisticated measures have been 
devised and used to measure physiologic changes in the baby arising in 
response to sound. Two primary methods are now used to check newborn 
hearing. Otoacoustic emission (OAE) testing uses a probe placed within the 
infant's ear to measure inner-ear responses to sound. Automated Auditory 
brainstem response (AABR) uses electrodes placed on the infant's head to 
measure brain-wave responses to clicks administered to the ear. These 
methods are more accurate for infants under 6 months of age than behavioral 
assessment.These tests have been recommended by AAP and JCIH.Both 
hearing screening methods are objective and physiologic measures that do 
not need the active patient response required in traditional audiologic 
evaluation tests27. 
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Hearing screening tests provide a quick and cost effective way to 
separate people into two groups: a pass group and a fail group. Those who 
pass hearing screening are presumed to have no hearing loss. Those who fail 
are in need of an in-depth evaluation by an audiologist. 
All of the tests described above are safe and non-invasive.Some skin 
abrasions from the electrodes are the only complications associated with  
AABR; no complications are reported from OAE testing. Otoacoustic 
emission testing can be done with the infant awake, feeding, or sucking on a 
pacifier. AABR requires the infant to be asleep. 
 There are 3 steps in the Hearing Screening program. 
• Screening 
• Confirmation (Audiologic evaluation of those with abnormal result) 
and 
• Early intervention for those with confirmed hearing impairment. 
OTOACOUSTIC EMISSIONS(OAE) 
Oto acoustic emissions were first described by KEMP in 1978.In 
healthy cochlea,vibration of hair cells in response to noise generates acoustic 
energy known as OAE.An OAE is a weak echo type inaudible sound emitted 
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by the ear soon after an  audible sound is perceived.The OAE measures 
stimulated acoustic energy  generated in cochlea (inner ear) that travels 
through the  middle ear into the ear canal where it is sensed with a miniature 
microphone. OAE is very sensitive, noninvasive, cost and time effective 
making it an ideal screening method.26 
OAE testing therefore measures the integrity of inner ear. Persons 
with normal hearing produce emissions. Those with hearing loss greater than 
25 – 30 decibels do not. OAEs can detect blockage in outer canal,middle ear 
fluid or damage to outer hair cells in the cochlea. 
To perform the OAE,a tiny flexible plug is inserted into baby’s 
ear.Specific sounds are generated through the plug.A miniature microphone 
in the plug records the otoacoustic responses of the inner ear in reaction to 
transmitted sounds.The test is usually done when the baby sleep . 
Automated OAE screeners display the results of the test as either 
‘PASS’ or ‘REFER’requiring no interpretation by screening personnel. 
Refer means either the ear is abnormal or there is false positive result due to 
debris in the external canal. This test takes between 1-5 minutes to perform. 
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OAE INSTRUMENT 
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AUTOMATED AUDITORY BRAINSTEM RESPONSE(AABR) 
 The AABR provides complete screening of auditory pathway upto the  
brainstem(including middle ear, inner ear and 8th N). When AABR is 
performed electrodes are placed on the forehead, nape of neck and 
shoulder(ground). With AABR screening ,a click stimulus at one loudness 
level is provided to each of the child’s ears.The child’s response is compared 
to a template of children with normal hearing. If the responses match, the 
child passes the screening; If they do not match then child has hearing 
impairment. Screening by AABR can be completed after birth and a 
stringent statistical pass criterion is employed that eliminates bias from 
interpretation.AABR is a screening tool for infant who have reached atleast 
34  weeks conceptional age until the child turns 6 months of age.12 
           Responses from a large numbers of stimulus presentations are 
averaged and the automated screener uses a response algorithm to produce a 
PASS or REFER result.The pass level is set at about 35 decibels           
Babies are sedated to minimize electrical interference caused by muscle 
activity during testing. In a normal person 7 waves are produced in the first 
10 milliseconds. Waves I,III and V can be obtained consistently in all age 
groups.Waves II and IV appear less consistently.The latency of each 
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wave(time of onset of wave peak after stimulus onset) increases and the 
amplitude decreases with reduction in stimulus intensity or loudness.1,3 
 The exact anatomic site of origin of waves is still disputed but they 
are thought to arise from following parts. 
TABLE – 3 
SITE OF ORIGIN OF WAVES 
 
 
 
 
WAVE I 
 
 
VIII NERVE 
 
WAVE II 
 
 
COCHLEAR NUCLEI(PONS) 
 
WAVE III 
 
 
SUPERIOR OLIVARY COMPLEX(PONS) 
 
WAVE IV 
 
 
LATERAL LEMNISCUS(PONS) 
 
WAVE V 
 
 
INFERIOR COLLICULUS(MIDBRAIN) 
 
WAVE VI 
 
 
MEDIAL GENICULATE BODY(THALAMUS) 
 
WAVE VII 
 
 
AUDITORY RADIATIONS(THALAMO CORTICAL) 
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WHO SHOULD BE SCREENED? 
           Ideally all infants have to be screened for congenital and neonatal 
onset hearing loss prior to the discharge from the hospitals where they were 
born. If this is not feasible due to financial constraints, then infants with the 
following risk factors should DEFINITELY be screened.1,2,4,10,19 
1. An illness or condition requiring admission of 24 hours or more in 
NICU. 
2. Birth weight less than 1,500 grams (3.3 lbs.). 
3. Apgar scores of  0- 4 at 1 minute ; 0-6 at 5 minutes. 
4. Hyperbilirubinemia at a serum level requiring exchange transfusion. 
5. Ototoxic medications –Aminoglycosides and loop diuretics used for 
>5 days 
6. Mechanical ventilation lasting 5 days or longer and PPHN. 
7. Bacterial meningitis. 
8. In utero infections by TORCH group of organisms. 
9. Craniofacial anomalies, including those with morphological 
abnormalities of the pinna and ear canal. 
10. Stigmata or other findings associated with a syndrome known to 
include a sensorineural and/or conductive hearing loss such as 
Waardenburg syndrome (pigmentary abnormalities),branchiootorenal 
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syndrome (ear tags or pits), Usher syndrome(retinitis pigmentosa), 
Pendred syndrome (thyroid enlargement), Jervell and Lange-Nielsen 
syndrome(cardiac conduction defects). 
11. Family history of permanent childhood sensorineural hearing loss. 
While high risk newborns do have much higher rates of hearing 
impairment, they account for only about 50 percent of all newborns with 
hearing loss at birth.  
A consequence of screening only high risk neonates is that 
approximately only one in ten newborns is screened, and only about half of 
all hearing impaired infants are detected at birth.18 
WHAT HAPPENS IF AN INFANT DOES NOT PASS THE 
SCREENING?10,14,16,20 
Infants who do not pass the first screening by OAE  are subjected to 
second screening by OAE after one month. Rescreening reduces the false 
positive rates13,14.  
 If second screening is also abnormal,then the infant is subjected to 
AABR(Task Force on newborn and infant hearing) and then referred for 
follow-up audiological (electrophysiologic measure of threshold using, 
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frequency specific stimuli) and medical evaluations that should occur no 
later than 3 months of age. These evaluations confirm the presence of 
hearing loss; determine the type, nature, and (whenever possible) the cause 
of the hearing loss; and help to identify options for treatment. Intervention 
for hearing loss must be initiated before 6 months of age. 
SENSITIVITY AND SPECIFICITY26 
           Sensitivity of OAE  is 80 – 98% and that of AABR is 84-90%. 
           Both methods have specificity >90%. 
TEST LIMITATIONS26 
          Both OAE and AABR require a quiet baby and a quiet testing 
environment.OAE relies on a functional outer, middle and inner ear and 
AABR in addition  relies on functional lower auditory pathway.The 
screening tests are not designed to detect central hearing impairment (where 
there is hearing loss secondary to dysfunction of pathways from the 
brainstem to the auditory cortex). 
         As the stimuli for both tests are introduced via external ear canal,debris 
in the canal or middle ear fluid can affect accuracy of test.In particular, OAE 
testing may be affected by amniotic fluid in the ear canal when testing is 
done in the first 48 hours after birth. 
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INTERVENTION FOR HEARING IMPAIRMENT 
           Numerous professionals are involved in offering services to a child 
with hearing impairment including.  
• The Audiologist and audiological team  
• Primary care Paediatrician  
• Speech Therapist 
• Otorhinolaryngologist 
• Plastic Surgeon 
• Alternative Language Teachers 
HEARING AIDS FOR CHILDREN 
Fitting and programming hearing aids for infants and children should 
be done by a qualified paediatric audiologist.Both BTE (behind the ear) and 
ITE (in the ear) hearing aids are used to amplify sound for hearing impaired 
children. ITE hearing aids sit completely inside of the ear. While ITE 
hearing aids may be used by older children, they aren't recommended for 
infants and younger children.  
During infancy and early childhood the size and shape of the ear 
changes as the child grows. BTE hearing aids are safer and can be utilized 
longer.Hearing aids may be fitted for infants as early as 2 months. 
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              IN THE EAR HEARING AID 
 
 
 
COCHLEAR IMPLANTS 
 In some situations hearing aids are not very effective. When there is 
profound sensorineural hearing loss,cochlear implants may be an option. A 
cochlear implant is an electronic device. There is an external component and 
surgically implanted internal component. The external component picks up 
the sound, converts it to electronic impulses and then relays the information 
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to the internal device. Impulses are collected by the receiver and then sent 
directly to the auditory nerve. 
A serious complication of cochlear implants is an excessively high 
incidence of pneumococcal meningitis.All children receiving a cochlear 
implant must be vaccinated with the Pneumococcal vaccine. 
HOW A COCHLEAR IMPLANT WORKS? 
1. Sounds are picked up by the microphone. 
2. The signal is then “coded”(turned into a specific pattern of electrical 
impulses).  
3. These impulses are sent to the coil and are transmitted across the skin 
to the implant.  
4. The implant sends a pattern of electrical impulses to the electrodes in 
the cochlea. 
5. The Auditory nerve picks up the electrical impulses and sends them to 
the brain.The  brain recognises these signals as sounds.  
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COCHLEAR IMPLANT 
                          
 
           
 
 
 
28 
 
Nagapoornima et al4 – Conducted a prospective non-randomised 
study to determine the incidence of hearing impairment in at risk and not at 
risk neonates in tertiary care hospital in Bangalore.The incidence of hearing 
impairment was 7 out of 1490(NOT AT RISK) and 3 out of 279(AT RISK). 
            Sharma et al12 – Conducted a study to evaluate BERA as an 
objective test of hearing assessment in icteric babies and concluded that 
BERA is a simple,reliable and effective technique for detection of hearing 
impairment in the neonates. 
            Vaid et al – Screened 2621 babies in a tertiary care hospital in Pune  
by OAE and BERA and found that 15 babies had significant hearing loss. 
            Bansal et al13 - Transient evoked otoacoustic emissions in hearing 
screening programs: protocol for developing countries – The objective of 
this program was to  formulate a protocol for infant hearing screening in 
developing countries enabling it to be later incorporated into their national 
deafness screening programs. 2659 infants in the age range of 0-3 months 
were included in study. They were divided into 3 groups with age range 
between 0-1, 1-2and 2-3 months of age. All were subjected to transient 
evoked otoacoustic emission (TEOAE) for hearing screening. Those who 
failed first screening were followed up after 1-month.  
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 Infants who had failed the second screening underwent Brainstem 
Evoked Response Audiometry (BERA). This study highlighted that delayed  
hearing screening at 3 months of age would considerably decrease the 
number of false positive cases avoiding  unnecessary investigations and 
wastage of resources making the universal neonatal hearing screening within 
48 h of life impractical for developing countries.Combining this delayed 
hearing screening with the 3rd dose of universal immunization program 
would constitute a viable, feasible and universal hearing screening program, 
which can be drafted into national deafness programs of the developing 
countries. 
           Heinemann et al14 – Conducted  a study to find the cost effectiveness 
of newborn hearing with different instruments and found that two step 
screening(first with OAE and then with BERA) was most cost effective. 
           Finckh Kramer et al5– Conducted a  prospective study  on the 
prevalence of hearing impairment in an at-risk neonatal intensive care unit 
(NICU) population. 
Sharma et al. and Dorman et al25. have shown that neural plasticity 
within the auditory system begins to decline after approximately 3.5 years of 
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age and that earlier intervention tends to result in normal or near-normal 
central auditory function. 
Philips et al.25 determined that earlier screenings led to more 
successful outcome among children who were diagnosed with profound 
hearing loss and promptly fitted with cochlear implants.They concluded that 
this earlier intervention resulted in improved auditory receptivs skills. 
            Apuzzo and Yoshinaga-Itano22 found that "infants who are 
identified with hearing loss early have a distinct advantage over their later 
identified peers" and "identification and intervention begun before 2-1/2 
years benefits all infants with hearing loss, regardless of hearing impairment. 
This benefit is especially evident for subjects who were identified by two 
months of age." 
            White and Maxon16  found universal newborn hearing screening to be 
more cost-effective than screening targeted only to infants considered high 
risk. 
         1993 National Institute of Health (NIH) Consensus  Development  
Panel  on Early Identification of Hearing Impairment in Infants and Young 
Children suggested Universal screening is superior to a hearing protocol that 
screens only "high-risk" newborns because the high-risk protocol identifies 
 
 
31 
 
only 50 percent of hearing-impaired infants.The preferred model for infant 
screening should be two-stage beginning with an   otoacoustic emissions test 
(OAE) and should be followed by an auditory brainstem response test 
(ABR) for all infants who fail the OAE test18. 
        Kurt et al 8– Stated that  OAE testing can be accomplished easily in a 
normal newborn nursery with an acceptable false-positive rate when a two-
stage approach is used. 
        Kittrell et al17revealed that average age of identification of hearing 
impairment was 20.2 months and average age of initial amplification was 
31.7 months and two years after universal screening implementation,the 
everage age at diagnosis has improved to 3.8 months of age. 
         Karen Jo Doyle et al compared pass rates for two different hearing 
screening methods in well newborns as a function of age. Hearing screening 
tests were performed on 400 ears in 200 healthy newborn infants at the 
University of California-Irvine Medical Center. There was no significant 
difference in the AABR pass rate for infants aged 0–24 h of age as compared 
with infants aged >24 h.  
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However, the OAE pass rate improved significantly in infants >24 h 
compared with the group aged 0–24 h (P < 0.01). 
 M D Mohd Khairi et al15 conducted 2 stage hearing assessment in  
401 at risk neonates  and concluded that mechanical ventilation of more than 
5 days was not an independent risk factor for hearing impairment. 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
AIM AND OBJECTIVES 
AIM : 
 To assess the hearing status of newborns admitted in our NICU with 
risk factors for hearing  impairment. 
OBJECTIVES : 
          To set the new screening criteria for hearing assessment for babies 
with high risk factors, admitted in NICU of Government Rajaji 
Hospital,Madurai. 
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MATERIALS AND METHODS 
a)Study Design : 
             Prospective study 
b) Study Place : 
             Neonatal intensive care unit (NICU), Institute of child health and 
research centre, Government Rajaji Hospital,   Madurai- 20. 
 
c) Study Period : 
             October 2009 to October 2010 
 
d) Study Population : 
             Babies admitted in NICU of Government Rajaji Hospital, Madurai. 
 
e) Inclusion Criteria : 
            All newborns with the following risk factors were enrolled for study. 
1. Birth weight less than 1,500 grams (3.3 lbs.).  
2. Apgar scores of  0- 4 at 1 minute ; 0-6 at 5 minutes. 
3. Hyperbilirubinemia at a serum level requiring exchange transfusion 
4. Ototoxic medications – Aminoglycosides and Loop diuretics used for 
>5 days 
5. Mechanical ventilation lasting 5 days or longer. 
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6. Bacterial meningitis. 
7. In utero infections by TORCH group of organisms. 
8. Craniofacial anomalies, including those with morphological 
abnormalities of the pinna and ear canal. 
9. Stigmata or other findings associated with a syndrome known to 
include a sensorineural and/or conductive hearing loss. 
10. Family history of permanent childhood sensorineural hearing loss. 
METHODOLOGY 
              All newborns with the above mentioned risk factors admitted in the 
NICU were screened for hearing impairment between October 2009 to 
October 2010. A total of 100 babies were subjected to OAE prior to 
discharge. Information collected regarding the selected cases were recorded 
in the master chart. 
 
            Babies with severe birth asphyxia (apgar 0-4 at 1 min and 0-6 at 5 
min) were subjected to OAE after they met the discharge criteria              
Babies with hyperbilirubinemia were subjected to OAE after exchange 
transfusion and phototherapy reduced bilirubin to safe levels as per standard  
protocol.  
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            Meningitis was diagnosed based on standard guidelines( CSF cell 
count and biochemical analysis) and babies were screened after they were 
completely treated. 
 
            Preterm babies with Very Low Birth Weight (Birth weight between 
1000g to 1400g), babies who received ototoxic drugs and babies who were 
on ventilator were screened after they met the discharge criteria.  
 
            Two babies with craniofacial malformation were screened. One baby 
had defects in both eyes( microophthalmos, microcornea in left eye and 
blurred disc margin  and optic nerve head dysplasia in the right side) and 
ear(microtia left side).CT scan of the baby showed contracted left eye with 
calcified focus in globe. Another baby had bilateral microtia with atresia of 
external auditory canal. 
 
A baby was suspected as TORCH infection based on clinical findings 
(hepatosplenomegaly,petechiae,purpura and elevated direct bilirubin) and  
was screened on the day of discharge. 
 
            The initial examination was carried out by means of OTO 
ACOUSTIC EMISSIONS (OAE).If the initial screening is normal. then 
the hearing is presumed to be normal and the neonate is advised follow up 
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every 6 months upto 3 years. If the initial screening is abnormal, then the 
newborn is subjected to SECOND screening again by OAE after one 
month. If the second screening is normal, then the hearing is presumed to be 
normal and the baby is advised follow up every 6 months upto 3 years.If the 
second screening is abnormal,then the baby is subjected to AUTOMATED 
AUDITORY BRAINSTEM RESPONSE (AABR).Based on the results of 
AABR, early intervention is done. 
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OBSERVATION, ANALYSIS AND RESULTS 
 
During this study,100 high risk babies were subjected to OAE testing. 
The age of the study group ranged between 3 days to 90 days.55 
babies(55%) were male and 45 babies(45%) were female. The gestational 
age of the study group ranged between 30 to 38 weeks. Birth weight varied 
between 1000g and 3800g. 2 babies dropped out after the first screening test. 
At the end of two stage screening test,95 babies(96.9%)  had normal hearing 
and 3 babies(3.1%) had hearing impairment(2 babies were male and 1 was 
female).Of the 3 babies, 2 babies had severe birth asphyxia and 1 baby had 
craniofacial malformation. 
 
 Total babies screened initially by OAE           : 100 
Total babies who passed first screening by OAE            : 84(84%) 
Total babies who failed first screening by OAE              : 16(16%) 
Drop outs after first  screening                                    : 02(12.5%) 
 Total babies subjected to second screening by OAE      : 14(87.5%) 
Total babies who passed after second screening by OAE : 12(85.7%) 
 Total babies who failed after second screening by OAE : 02(14.3%) 
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Babies for whom OAE could not be done  
due to craniofacial malformation             :  01(1%)   
Total number of babies for whom  
AABR is done                :  03(3.1%)  
 
3 babies were diagnosed to have hearing impairment out of 98 high 
risk babies ( mean = 0.03, S.D = 0.17). The incidence rate is 3.1% which is 
similar to other studies done (2.5 -10%). 
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TABLE - 4 
RISK FACTORS SCREENED 
 
RISK FACTOR MALE FEMALE PERCENTAGE
SEVERE BIRTH ASPHYXIA 28 24 52 
VLBW 10 10 20 
MENINGITIS 06 04 10 
HYPERBILIRUBINEMIA 04 04 08 
OTOTOXIC DRUGS 03 01 04 
VENTILATED BABIES 02 01 03 
CRANIOFACIAL ANOMALY 02 00 02 
STIGMATA OF TORCH 00 01 01 
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TABLE – 5 
STUDY POPULATION 
 
ENROLLED 100 
COMPLETED FOLLOW UP 98 
DROP OUTS 02 
 
 
 
 
TABLE-6 
SEX DISTRIBUTION OF SCREENEED INFANTS 
 
SEX NUMBER PERCENTAGE  
MALE  55 55% 
FEMALE  45 45% 
TOTAL  100 100% 
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TABLE - 7 
SCREENING OF INDIVIDUAL RISK FACTORS 
SEVERE BIRTH ASHYXIA 
 
FIRST SCREENING  
BY OAE 
  
SECOND SCREENING
 BY OAE 
 
52 
TOTAL BABIES 
SCREENED  
 
06 
 
45 
NORMAL 
HEARING  
 
04 
 
02 
IMPAIRMENT IN  
ONE EAR  
 
01 
 
05 
IMPAIRMENT IN 
BOTH EARS  
 
01 
 
            Of the 52 babies with birth asphyxia,45 babies passed the first 
screening. 2 babies had impairment in 1 ear and 5 babies had impairment in 
both ears. These 7 babies were planned second screening by OAE after one 
month. Of  these 7 babies, 4 babies passed the second screening. 1 baby with 
impairment in both ears dropped out and 2 babies failed. Those 2 babies 
were subjected for AABR. 
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TABLE - 8 
VERY LOW BIRTH WEIGHT 
 
 
FIRST SCREENING 
 BY OAE 
  
SECOND SCREENING 
BY OAE 
 
20 
TOTAL BABIES 
SCREENED  
 
04 
 
16 
NORMAL 
HEARING  
 
04 
 
03 
IMPAIRMENT IN  
ONE EAR  
 
00 
 
01 
IMPAIRMENT IN 
BOTH EARS  
 
00 
 
            Of the 20 babies with very low birth weight,16 babies passed the first  
screening.3 babies had impairment in 1 ear and 1 baby had impairment in 
both ears. All these 4 babies were subjected to second screening by OAE 
after one month. All the 4 babies who failed in the first screening passed 
when subjected to second screening by OAE after 1 month and had normal 
hearing. 
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TABLE - 9 
MENINGITIS 
 
FIRST SCREENING  
BY OAE 
  
SECOND SCREENING 
BY OAE 
 
10 
TOTAL BABIES 
SCREENED 
 
03 
 
07 
 
NORMAL HEARING 
 
03 
 
02 
IMPAIRMENT IN  
ONE EAR  
 
00 
 
01 
IMPAIRMENT IN  
BOTH EARS  
 
00 
 
            Of the 10 babies with meningitis,7 babies passed the first 
screeniong.2 babies had impairment in 1 ear and 1 baby had impairment in 
both ears. All these 3 babies were subjected to second screening by OAE 
after one month. All the 3 babies who failed in the first screening passed 
when subjected to second screening by OAE after 1 month. 
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TABLE - 10 
HYPERBILIRUBINEMIA REQUIRING EXCHANGE 
TRANSFUSION 
FIRST SCREENING 
BY OAE 
 SECONDSCREENING
 BY OAE 
 
08 
TOTAL BABIES 
SCREENED  
 
01 
06 NORMAL HEARING 01 
 
01 
IMPAIRMENT IN 
ONE EAR  
 
00 
 
01 
IMPAIRMENT IN 
BOTH EARS  
 
00 
 
 Of the 8 babies, for whom exchange transfusion was done for 
hyperbilirubinemia, 6 babies passed the first screeniong.1 baby had 
impairment in 1 ear and 1 baby had impairment in both ears. Baby which 
failed in both ears dropped out. Other baby was subjected to second 
screening by OAE after one month and the baby passed the second 
screening. 
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TABLE - 11 
OTOTOXIC DRUGS 
FIRST SCREENING BY OAE 
TOTAL BABIES SCREENED  04 
NORMAL HEARING 04 
HEARING IMPAIRMENT 00 
 
            4 babies who received ototoxic drugs were screened and all the 4 
babies passed the first screening by OAE. 
 
TABLE – 12 
VENTILATED BABIES 
FIRST SCREENING BY OAE 
TOTAL BABIES SCREENED 03 
NORMAL HEARING 03 
HEARING IMPAIRMENT 00 
 
            Of the 3 babies who were ventilated for 5 days,all the 3 babies 
passed the first screening by OAE.  
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TABLE – 13 
CRANIOFACIAL MALFORMATION 
FIRST SCREENING BY OAE 
TOTAL BABIES SCREENED  01 
NORMAL HEARING 01 
HEARING IMPAIRMENT 00 
 
 2 babies had craniofacial malformation.1 baby was directly subjected 
to AABR because OAE could not be done due to atresia of auditory canal. 
The other baby passed the first screening by OAE. 
TABLE – 14 
TORCH INFECTION 
FIRST SCREENING BY OAE 
TOTAL BABIES SCREENED  01 
NORMAL HEARING 01 
HEARING IMPAIRMENT 00 
 
 1 baby suspected as TORCH was screened and the baby passed the 
first screening by OAE. 
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TABLE – 15 
AABR FOR FAILED SECOND SCREENING TEST 
RISK FACTOR NO OF CASES
AABR DONE 
FINAL HEARING 
STATUS 
SEVERE BIRTH ASPHYXIA 02 ABNORMAL 
CRANIOFACIAL 
MALFORMATION 
01 ABNORMAL 
 
 3 babies were subjected to AABR and it was abnormal in all three 
babies.Hearing aids have been fitted with the help of ENT surgeon for 2 
babies and 1 baby is awaiting hearing aid as it is only 3 months old. 
 
TABLE – 16 
FINAL OUTCOME OF SCREENED INFANTS 
OUTCOME NUMBER OF CASES 
NORMAL HEARING 95 
HEARING IMPAIRMENT 03 
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TABLE - 17 
SEX DISTRIBUTION OF BABIES WITH HEARING IMPAIRMENT 
SEX NUMBER 
MALE 2 
FEMALE 1 
TOTAL 3 
 
TABLE – 18 
FINAL OUTCOME OF BABIES WITH RISK FACTORS 
RISK FACTOR TOTAL 
CASES 
NORMAL 
HEARING
HEARING     
IMPAIRMENT
SEVERE BIRTH ASPHYXIA 51 49 2 
VLBW 20 20 0 
MENINGITIS 10 10 0 
HYPERBILIRUBINEMIA 07 07 0 
OTOTOXIC DRUGS 04 04 0 
VENTILATED BABIES 03 03 0 
CRANIOFACIAL ANOMALY 02 01 1 
STIGMATA OF TORCH 01 01 0 
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TABLE 19 
CHI SQUARE TABLE 
 
 
RISK FACTOR 
NORMAL  
HEARING 
HEARING  
IMPAIRMENT 
TOTAL  
CASES 
SEVERE 
BIRTH ASPHYXIA 
 
49 
 
2 
 
51 
VLBW 20 0 20 
MENINGITIS 10 0 10 
HYPERBILIRUBINEMIA 07 0 07 
OTOTOXIC DRUGS 04 0 04 
VENTILATED BABIES 03 0 03 
CRANIOFACIAL ANOMALY 01 1 02 
STIGMATA OF TORCH 01 0 01 
 
Chi Square test has been applied to find the statistical significance of 
outcome of  risk factors. Chi Square value is 16.40.The p value is 
0.002.There is statistically significant difference among risk factors. 
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DISCUSSION 
 
Ideally all newborns should be screened for hearing loss prior to 
discharge from hospital where they were born. However in developing 
country like ours with limited resources,this is not always possible. Hence 
newborns with risk factors for hearing loss should atleast be screened. 
The incidence of hearing impairment in high risk neonates according 
to different statistics is 2.5% - 10%.10  In this study, the incidence is 3.1% 
which is similar to other studies.    
100 babies were subjected to OAE testing.16( 16%) babies failed 
after the first screening.They include 7 babies with birth asphyxia,4 babies 
with very low birth weight,3 babies who were treated for meningitis and 2 
babies for whom exchange transfusion was done for 
hyperbilirubinemia.2(12.5%)babies dropped out after the first screening 
test.12 out of 14(85.7%) babies passed the second screening by OAE.2 out 
of 14 babies(14.3%) failed after second screening by OAE and were 
subjected to AABR. Totally 3 babies were subjected to AABR( 2 babies 
who failed screening along with another baby who was directly subjected to 
AABR as the baby had atresia of external auditory canal)  and all the 3 
babies had abnormal AABR(3.06%). All 3 babies had profound hearing loss.  
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BIRTH ASPHYXIA 
52 babies with severe birth asphyxia were screened by OAE. 7 
(13.5%) babies failed the first screening  by OAE. Of these, 5 babies had 
impairment in both ears and 2 babies had impairment in one(left) ear. Both 
of them had associated Congenital heart disease.4 babies passed when 
subjected to second screening; 1 baby dropped out and finally 2 (3.9%) 
babies with birth asphyxia had hearing impairment at the end of 2nd 
screening. 
A study by Nagapoornima et al4 who screened 51 babies with severe 
birth asphyxia and identified hearing impairment in 1 baby. Christine Ohl 
et al7 screened 12 babies with severe birth asphyxia  and identified 4 babies 
with hearing impairment which is much higher than our study. 
VERY LOW BIRTH WEIGHT 
 Twenty babies with very low birth weight were by screened by OAE. 
4 (20%) babies failed the first screening by OAE. Of these 4, 3 babies had 
impairment in 1 ear and 1 baby had impairment in both the ears.All the 4 
babies passed when subjected to second screening by OAE. A study by 
Christine Ohl et al7 who showed  very low birth weight  is not a risk factor 
for hearing  impairment as in our study in which babies with VLBW had 
normal hearing. A study by Finckh Kramer U et al5 and Hess M et al6 also 
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concluded that VLBW was not a predictor of hearing impairment as in our 
study. 
MENINGITIS 
 Ten babies who were treated for meningitis were by screened by 
OAE.3 (30%) babies failed the first screening by OAE. Of these 3, 2 babies 
had impairment in 1 ear and 1 baby had impairment in both the ears. All the 
3 babies passed when subjected to second screening by OAE. 
Nagapoornima et al4 screened 14 babies with meningitis but none 
had hearing impairment as in our study. 
EXCHANGE TRANSFUSION 
Eight babies who underwent exchange transfusion for 
hyperbilirubinemia were by screened by OAE.2 (25%) babies failed the first 
screening by OAE.1 baby dropped out after the first screening.The other 
baby had impairment in left ear and passed when subjected to second 
screening by OAE.Nagapoornima et al4 screened 38 babies with severe 
hyperbilirubinemia requiring exchange transfusion but none had hearing 
impairment as in our study. This is due to early identification and effective 
management of hyperbilirubinemia. 
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OTOTOXIC DRUGS 
 Four babies who received ototoxic drugs for septicemia were screened 
by OAE and all the 4 babies passed the screening test. Finckh Kramer U et 
al5 concluded that aminoglycosides are not an important risk factor.Similar 
results were obtained by Hess M et al6 and our study also showed 
aminoglycosides are not a risk factor for hearing impairment  
VENTILATED BABIES 
 Three  babies who were ventilated for birth asphyxia and sepsis were 
screened and all the 3 passed the first screening by OAE. 
M D Mohd Khairi et al15 conducted 2 stage hearing assessment in 
401 at risk neonates  and concluded that mechanical ventilation of more than 
5 days was not an independent risk factor for hearing impairment. 
CRANIOFACIAL MALFORMATION 
 Two babies with craniofacial malformation were included in our 
study.1 baby passed the first screening by OAE.Other baby was directly 
subjected to AABR as the baby had bilateral atresia of external auditory 
canal and the baby had abnormal AABR. 
Nagapoornima et al4 screened 24 babies with craniofacial 
malformation but none had hearing impairment in contrast to our study in 
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which 1 of the 2 (50%) babies with craniofacial malformation had hearing 
impairment. 
TORCH INFECTION 
One baby was suspected as TORCH infection clinically and was 
screened and the baby passed the first screening by OAE. 
Nagapoornima et al4 screened 6  babies with TORCH infection but 
none had hearing impairment as in our study. 
 Out of 16 babies who failed after the first screening,2 dropped out. Of 
the remaining 14 babies, 12 babies passed when subjected to second 
screening. Finally 2 babies failed after 2nd screening. These 2 babies along 
with the baby who had craniofacial malformation were subjected to AABR 
and all the 3 babies had abnormal AABR. 
 So in our study of high risk screening, 3 babies had hearing 
impairment (3.1%)  out of 98and it is higher than the incidence of study by 
Nagapoornima et al4 who identified 3 out of 279 high risk babies(1.07%). 
 Christine Ohl et al4 screened 1461at risk  babies among whom 
4.55% were diagnosed as deaf which is higher than our study. 
 Finckh Kramer U et al5 screened 1062 at risk  neonates and 
identified hearing Impairment in 1.3% which is lower than our study. 
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 Sayed Hossein Fakhraee et al24 screened 150 high risk infants of 
whom 42(28%) had different  levels of hearing impairment. 
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CONCLUSION 
 
• In this study of 100 high risk babies, 3 babies(3.1%) had hearing 
impairment(profound hearing loss). 
• Of the 8 risk factors screened, only 2 risk factors (severe birth 
asphyxia and craniofacial malformation) were associated with hearing 
impairment. 
• 3.9%(2 out of 51) of babies with severe birth asphyxia and 50%(1 out 
of 2) of babies with craniofacial malformation had hearing 
impairment. 
• Hearing impairment is not seen in VLBW infants, Meningitis, 
Hyperbilirubinemia, Ventilated babies and those who received 
Ototoxic drugs probably due to early and effective management. 
• Hence early identification and intervention will allow deaf and hard of 
hearing children to develop language skills during a period of neural 
plasticity that would otherwise be forfeited, banishing them into a 
world of social isolation and educational malaise. 
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LIMITATIONS 
 
• Our study focused on high risk infants who constitute only 50% of 
all neonates with hearing loss. The other 50% will remain 
undetected at birth by this approach. 
• All high risk babies require hearing assessment every 6 months 
upto 3 years which could not be done in our study. 
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RECOMMENDATIONS 
Developing countries like India must take initiatives to implement 
newborn hearing screening programme. Initially a centralized screening 
facility can be established to implement this program. 
• Each District Hospital should run a program and the Audiologist 
should function as program co-ordinator. 
• All children born in the district should be screened at birth, or, 
within a month's time. Primary health centers and community 
health centers should make arrangements for referral. Cost 
effective behavioural observation methods using calibrated noise 
making toys may be taught to anganwadi workers and may be 
advised to refer to higher centres if needed. 
• New-borns who fail on screening, should be given a diagnostic test 
and proper interventions within 3 months. 
• Those who have high-risk for hearing loss should be followed up 
at intervals of 6 months even if they are cleared at the screening. 
If  resources are limited, then one could focus initially on high risk 
neonates and gradually implement universal screening. 
The message is – “Don’t take a chance, have a hearing testing done 
in all newborns”. 
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Both Ears : Peak ‘V’ couldn’t be observed even at 99 dBnHL          
 
                                                                        
 
Impression: 
 
Bilateral Severe to Profound Hearing Loss. 
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• Hearing aid Trial and fitting 
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• Follow up. 
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Results:
Both Ears : Peak ‘V’ couldn’t be observed even at 99 dBnHL
Impression:
Bilateral Severe to Profound Hearing Loss. 
Recommendation:
x Cochlear Implant Counselling 
x Hearing aid Trial and fitting 
x Speech and Language therapy 
x Follow up. 
                                                                                                        Baiju. K.S 
              Audiologist
BIRTH  WT APGAR AT  EXCHANGE  SEVERE BIRTH CRANIOFACIAL  OTOTOXIC  AABR RESULTS
RIGHT                   LEFT
1 B/O Perinbanayagi 6             F 1000 4/10;6/10 N N N N N N N P                       P                      
2 B/O Jeyakodi 13             F 1240 5/10;7/10 N N N N N N N P                       P                      
3 B/O Kesavapriya I 11            M 1400 5/10;7/10 N N N N N N N P                       P                      
4 B/O Kesavapriya II 11            M 1100 5/10;7/10 N N N N N N N P                       P                      
5 B/O Dhanabackiyam 7             F 1400 4/10;6/10 N N N N N N N P                       P                      
6 B/O Muthukili 14            M 1100 5/10;7/10 N N N N N N N P                       P                      
7 B/O Sathipriya 12            M 1200 5/10;7/10 N N N N N N N P                       P                      
8 B/O Sathya 16            M 1300 5/10;7/10 N N N N N N N P                       P                      
9 B/O Alagu 5             F  1100 4/10;7/10 N N N N N N N P                       P                      
10 B/O Jeyalakshmi 5             F 1200 5/10;7/10 N N N N N N N P                       P                      
11 B/O Seeni Syedammal 7             F 1100 4/10;6/10 N N N N N N N P                       P                      
12 B/O Sureka 21             F 1000 5/10;7/10 N N N N N N N P                       P                      
13 B/O Alagammai 17            M 1250 5/10;8/10 N N N N N N N P                       P                      
14 B/O Roopa 8             F 1200 4/10;6/10 N N N N N N N P                       P                      
15 B/O Raghavi 6             F 1100 5/10;7/10 N N N N N N N P                       P                      
16 B/O Anusha Devi 4            M 1400 5/10;7/10 N N N N N N N P                       P                      
17 B/O Parimalam 8             F 1400 4/10;6/10 N N N N N N N P                       P                      
18 B/O Muniyammal 12            M 1400 3/10;7/10 N N N N N N N P                       P                      
19 B/O Poonkodi 12            M 1250 4/10;7/10 N N N N N N N P                       P                      
20 B/O Manjula 17            M 1200 4/10;7/10 N N N N N N N P                       P                      
21 B/O Ramila 7            M 2300 3/10;5/10 N             Y N N N N N P                       P                      
22 B/O Maheshwari 6             F 2700 2/10;5/10 N             Y N N N N N P                       P                      
23 B/O Gopala Krishnammal 6            M 3000 2/10;4/10 N             Y N N N N N P                       P                      
24 B/O Karthigai Selvi 4             F 3100 2/10;5/10 N             Y N N N N N P                       P                      
25 Jothi Eswar 5            M 1900 3/10;5/10 N             Y N N N N N P                       P                      
26 B/O Rathinam 8            M 2700 2/10;4/10 N             Y N N N N N P                       P                      
27 B/O Mareeswari 5             F 2400 2/10;5/10 N             Y N N N N N R R
28 Krithik Roshan 4            M 2600 2/10;4/10 N             Y N N N N N P                       P                      
29 B/O Muthumari 6            M 2300 3/10;5/10 N             Y N N N N N P                       P                      
30 B/O Mariyam 5            M 2200 2/10;5/10 N             Y N N N N N P                       P                      
31 Ali Akbar 11            M 1800 2/10;5/10 N             Y N N N N N P                       P                      
32 B/O Mehar Nisha 7             F 3000 2/10;4/10 N             y N N N N N P                       P                      
33 B/O Jegar Banu 6             F 2700 3/10;5/10 N             Y N N N N N P                       P                      
34 Sivasakthi 8             F 2600 2/10;5/10 N             Y N N N N N R R                  A
35 B/O Sivashankaraselvi 6             F 2400 2/10;4/10 N             Y N N N N N P                       P                      
36 B/O Kavitha 7            M 2800 3/10;5/10 N             Y N N N N N P                       P                      
37 B/O Revathy 8            M 2900 2/10;4/10 N             Y N N N N N P                       P                      
38 B/O Nagarathinam 6             F 3600 3/10;5/10 N             Y  N N N N N P                       P                      
39 B/O Rajalakshmi 7             F 3100 3/10;5/10 N             Y N N N N N P                       P                      
40 B/O Pavithra 8            M 2400 2/10;4/10 N             Y N N N N N P                       P                      
41 B/O Sasikala 8            M 2300 2/10;4/10 N             Y N N N N N P                       P                      
1 & 5 MIN   NAME
 AGE (IN 
DAYS)S.No      SEX (IN GRAMS)  TORCH
       OAE RESULTS
TRANSFUSION  ASPHYXIA MENINGITIS VENTILATED  ANOAMLY DRUGS
42 B/O Bhavani 4             F 2700 2/10;5/10 N             Y N N N N N P                       P                      
43 B/O Karthiga 6            M 2600 2/10;4/10 N             Y N N N N N P                       P                      
44 B/O Sharmila 5             F 2400 3/10;5/10 N             y N N N N N P                       P                      
45 B/O Asha 5            M 2400 2/10;4/10 N             Y N N N N N P                       P                      
46 B/O Shanmugapriya 6            M 3000 2/10;5/10 N             Y N N N N N P                       P                      
47 B/O Podhumponnu 7             F  3100 2/10;5/10 N             Y N N N N N P                       P                      
48 B/O Jansirani 6             F  3300 2/10;4/10 N             Y N N N N N P                       P                      
49 B/O Sivapriya 5             F 3500 3/10;5/10 N             Y N N N N N P                       P                      
50 Mayathevan 7            M 2100 3/10;5/10 N             Y N N N N N R R                   A
51 B/O Basheera Banu 7             F 2100 2/10;4/10 N             y N N N N N P                       P                      
52 B/O Umamaheshwari 6             F 2600 2/10;5/10 N             Y N N N N N P                       P                      
53 B/O Rajalakshmi 6            M 2600 2/10;5/10 N             Y N N N N N P                       P                      
54 B/O Kalaivani 6            M 2400 2/10;4/10 N             Y N N N N N P                       P                      
55 B/O Kokila 5            M 2800 3/10;5/10 N             Y N N N N N P                       P                      
56 B/O Poomari 5             F 2900 2/10;4/10 N             Y N N N N N P                       P                      
57 B/O Pandimeenakshi 5            M 2900 3/10;5/10 N             Y N N N N N P                       P                      
58 B/O Saritha 6             F 3000 2/10;4/10 N             Y N N N N N P                       P                      
59 B/O Saraswathi 6             F 2100 2/10;5/10 N             Y N N N N N P                       P                      
60 B/O Anandhi 5            M 2000 3/10;5/10 N             Y  N N N N N P                       P                      
61 B/O Dhanabackiyalakshmi 5             F 2300 2/10;4/10 N             Y N N N N N P                       P                      
62 Yogesh kumar 5            M 2100 2/10;4/10 N             Y N N N N N P                       P                      
63 B/O Kattuarani 5            M 2000 3/10;5/10 N             Y N N N N N P                       P                      
64 B/O Punitha 7            M 2500 2/10;4/10 N             Y N N N N N P                       P                      
65 B/O Umamaheshwari 7             F  2700 2/10;4/10 N             Y N N N N N P                       P                      
66 B/O Shobana 6             F 2800 3/10;5/10 N             Y N N N N N P                       P                      
67 B/O Pandeeswari 8             F 2500 2/10;5/10 N             Y N N N N N P                       P                      
68 B/O Sathyapriya 7             F  2800 2/10;4/10 N             Y N N N N N P                       P                      
69 B/O Kumareswari 7            M 2600 3/10;5/10 N             Y N N N N N P                       P                      
70 B/O Revathy 6            M 2800 3/10;5/10 N             Y N N N N N P                       P                      
71 B/O Amsavalli 9            M 2100 2/10;4/10 N             Y N N N N N P                       P                      
72 B/O Anis Fathima 6            M 2000 2/10;5/10 N             Y N N N N N P                       P                      
73 B/O Sathish rani 17            M 3800 6/10;8/10 N N            Y N N N N P                       P                      
74 B/O Bargath Nisha 7             F 3600 6/10;8/10 N N            Y N N N N P                       P                      
75 B/O Banumathi 14             F 3400 7/10;8/10 N N            Y N N N N P                       P                      
76 B/O Renganayaki 11            M 3100 3/10;6/10 N             Y            Y N N N N P                       P                      
77 B/O Manjula Devi 23            M 3400 3/10;6/10 N             Y            Y N N N N P                       P                      
78 B/O Shanmugavalli 3            M 2750 7/10;8/10 N N            Y N N N N P                       P                      
79 B/O Sangeetha 5            M 2600 7/10;8/10 N N            Y N N N N P                       P                      
80 B/O Nagalakshmi 11            M 3000 7/10;8/10 N N            Y N N N N P                       P                      
81 B/O Hemalatha 4             F 2800 7/10;8/10 N N            Y N N N N P                       P                      
82 B/O Sulochana 3            M 2400 7/10;8/10 N N            Y N N N N P                       P                      
83 Madesh 3            M 3000 3/10;5/10              Y             Y N N N N N P                       P                      
84 B/O Devika 3             F 2750 6/10;8/10              Y N N N N N N P                       P                      
85 B/O Revathy 6            M 3100 6/10;8/10              Y N N N N N N P                       P                      
86 B/O Vallupriya 4             F 2600 3/10;5/10              Y             Y N N N N N P                       P                      
87 B/O Podhumani 4             F 3000 6/10;8/10              Y  N N N N N N P                       P                      
88 B/O Parameshwari 4            M 2600 7/10;9/10              Y N N N N N N R R
89 B/O Nagajothi 4            M 2800 7/10;9/10              Y N N N N N N P                       P                      
90 B/O Katheeja Banu 3             F 3200 6/10;8/10              Y N N N N N N P                       P                      
91 B/O Sonia 15            M 3200 6/10;8/10 N N N N N          Y N P                       P                      
92 B/O Murugayee 17            M 3100 6/10;8/10 N N N N N          Y N P                       P                      
93 B/O Nagalakshmi 13             F 3000 3/10;6/10 N             Y N N N          Y N P                       P                      
94 B/O Amsavalli 10             F 2900 3/10;6/10 N             Y N N N          Y N P                       P                      
95 B/O Shanmugavalli 26            M 2300 5/10;7/10 N N N           Y N N N P                       P                      
96 Velmurugan 24            M 2900 3/10;6/10 N             Y N           Y N N N P                       P                      
97 B/O Santhanalakshmi 9             F 2500 3/10;5/10 N             Y N           Y N N N P                       P                      
98 Balamurugan 21            M 3100 6/10;8/10 N N N N               Y N N P                       P                      
99 Madhan Kumar 25            M 2700 6/10;8/10 N N N N               Y N N R R                  A
100 B/O Nagajothi 15             F 2700 6/10;8/10 N N N N N N        Y P                       P                      
 
 
Brainstem Auditory Evoked Response 
 
 
Medical Record Number :     10519                               Date: 27.01.2010 
 
 
Name    : M. Mayadevan     
   
     
Age / Sex   : 2 ½ months ; male  
      
 
Results: 
 
Both Ears: Peak V could not be observed till 99dBnHL    
 
 
 
 
Impression: 
 
Both Ears:  Severe to Profound Hearing Loss 
 
 
                                                                       
 
Recommendation: 
 
• Hearing Aid Trial 
• Follow up. 
                                                                                                        
                                                                                                                Asha Manoharan  
                                                                                                                   Audiologist 
 
 
                     
 
 
 
Audiological Report 
 
M.R No: 10519                                                 Date: 27.01.2010 
 
Name     :       M. Mayadevan 
 
Age / Sex:     2 ½ months ; male  
      
     
Immittance Audiometry:  
       
      Both Ears- ‘A’ Type with reflexes absent  
  S/o Normal middle ear functioning. 
OAE: 
 
      Both Ears – Emissions absent  
S/o OHC dysfunctioning. 
 
ABR: 
 Both Ears – Peaks could not be identified till 99dBnHL 
 
 
ASSR: 
Both Ears – Profound Hearing Loss 
             
Provisional Diagnosis:  
 
     Bilateral profound hearing loss    
        
Recommendation: 
                          
 Hearing Aid Trial and fitting 
 Speech and language evaluation and therapy 
 Special education 
 Follow Up 
                                                                                                              Asha Manoharan 
                              Audiologist 
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PROFORMA 
Name    :     I.P.NO.  : 
Age    :     Address        : 
Sex       :  
Date of birth   : 
Term / Preterm  :        
Birth Place    : 
Birth Weight  : 
Apgar at 1 & 5 min : 
RISK FACTORS 
Birth asphyxia       Y/N 
VLBW        Y/N  
Hyperbilirubinemia requiring exchange transfusion Y/N 
Meningitis        Y/N  
Ototoxic drugs       Y/N 
Mechanical Ventilation      Y/N 
Craniofacial Malformation     Y/N 
TORCH Infection       Y/N 
Family h/o childhood hearing loss    Y/N 
SCREENING METHOD BY OAE 
      
 
 
 
 
CONFIRMATION BY AABR 
 RIGHT EAR LEFT EAR 
AABR Normal/Abnormal Normal/Abnormal 
 
 
RESULTS 
 
 
 
 
 
 
 RIGHT EAR LEFT EAR 
FIRSTSCREENING  PASS REFER PASS  REFER 
SECONDSCREENING PASS REFER PASS  REFER 
ABBREVIATIONS 
 
DCN  Dorsal  Cochlear  Nucleus 
VCN  Ventral  Cochlear  Nucleus 
NIH  National Institute of Health 
NICU  Neonatal Intensive Care Unit 
JCIH  Joint Committee on Infant Hearing 
EHDI  Early Hearing Detection and Intervention 
CDC  Centre for Disease Control 
OAE  Oto Acoustic Emissions 
AABR Automated Auditory Brainstem Response 
VLBW Very Low Birth Weight 
 
 
 
